Health
Johnson & Johnson COVID-19 vaccine candidate enters late-stage trials | News – Daily Hive
One shot, instead of two.
Pharma giant Johnson & Johnson has announced its COVID-19 vaccine candidate has entered the late-stage trials.
The pharmaceutical company said about 45,000 participants are currently enrolled in the trials, with interim data expected by the end of January 2021.
If the Johnson & Johnson vaccine candidate proves effective, the company says it will submit an emergency use authorization application to the US Food and Drug Administration (FDA) in February.
Johnson & Johnson’s study, named Ensemble, was…
-
Noosa News21 hours agoHow Lily Steele-Park took her rapist to court and won
-
Noosa News22 hours agoE-biker charged with riding dangerously, assaulting cop
-
Business24 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025
-
General20 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands